GlassScriptPhysician profile
Vipin Bansal
NPI 1518954577
$1,433.97
in general payments reported to CMS, 2019-2025
9 companies · $396 in 2025
The $396 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.28 · 2020: $16.89 · 2021: $58.73 · 2022: $86.20 · 2023: $382 · 2024: $479 · 2025: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,256.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $537.70 | 2021-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $422.30 | 2022-2025 | Abre, Mvp, Hawkone |
| Penumbra, INC. | $145.20 | 2023-2025 | Indigo System |
| Stryker Corporation | $109.33 | 2025 | Flowtriever, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $76.78 | 2019-2023 | |
| Bard Peripheral Vascular, INC. | $48.87 | 2024-2025 | Covera |
| Cook Medical LLC | $46.74 | 2020-2025 | Torcon Nb |
| Cardiva Medical, INC. | $33.06 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Terumo Medical Corporation | $13.99 | 2024 | Glidesheath Slender, Angio-Seal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vipin Bansal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.